SAVA · Cassava Sciences
Cassava Sciences, Inc., a clinical-stage biotechnology company, develops drugs for neurodegenerative diseases. The company is headquartered in Austin, Texas.
6801 N. CAPITAL OF TEXAS HIGHWAY, AUSTIN, TX, UNITED STATES, 78731, Austin, TX, 78731, USA
BIOTECHNOLOGY
HEALTHCARE
Market Cap
115M
52 Wk Range
$1.20 - $4.98
Previous Close
$2.38
Open
$2.38
Volume
N/A
Day Range
$2.38 - $2.38
Enterprise Value
-23.77M
Cash
86.57M
Avg Qtr Burn
-8.878M
Insider Ownership
12.79%
Institutional Own.
28.98%
Qtr Updated
Mar 31st 2026